Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases Mechanisms and Cytoprotective Molecules
Neurogenerative diseases encompass very different pathologies, which can be demyelinating or nondemyelinating, but which have common mechanisms such as cell death, oxidative stress and inflammation. A better understanding of these mechanisms allows the search for biomarkers and targets for new thera...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_78746 | ||
005 | 20220224 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220224s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-2911-0 | ||
020 | |a 9783036529110 | ||
020 | |a 9783036529103 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-2911-0 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Vejux, Anne |4 edt | |
700 | 1 | |a Vejux, Anne |4 oth | |
245 | 1 | 0 | |a Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases |b Mechanisms and Cytoprotective Molecules |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (232 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Neurogenerative diseases encompass very different pathologies, which can be demyelinating or nondemyelinating, but which have common mechanisms such as cell death, oxidative stress and inflammation. A better understanding of these mechanisms allows the search for biomarkers and targets for new therapies. This special issue brings together different data on Alzheimer's disease, Parkinson's disease, and multiple sclerosis, detailing the mechanisms of cell death (necroptosis, ferroptosis), oxidative stress and inflammation but also the possibilities of neuroprotection via 5 research articles and 6 review articles. The different reviews allow us to take stock of cell death, oxidative stress and neuroinflammation in the context of neurodegenerative diseases but also in relation to other pathologies where these processes are involved. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a ferroptosis | ||
653 | |a cell death | ||
653 | |a iron metabolism | ||
653 | |a neurodegenerative diseases | ||
653 | |a glutathione peroxidase 4 | ||
653 | |a GSH | ||
653 | |a system xc− | ||
653 | |a Alzheimer's disease | ||
653 | |a Parkinson's disease | ||
653 | |a Huntington's disease | ||
653 | |a breast cystic fluid | ||
653 | |a clozapine | ||
653 | |a endocytosis | ||
653 | |a glia | ||
653 | |a neurons | ||
653 | |a ROS | ||
653 | |a neuroprotection | ||
653 | |a neuroinflammation | ||
653 | |a catechin | ||
653 | |a L-α-phosphatidylcholine | ||
653 | |a phosphatidylserine | ||
653 | |a brain ischemia | ||
653 | |a stroke | ||
653 | |a microglia | ||
653 | |a astrocytes | ||
653 | |a T lymphocytes | ||
653 | |a monocytes | ||
653 | |a platelets | ||
653 | |a macrophages | ||
653 | |a leukocytes | ||
653 | |a neutrophils | ||
653 | |a MPTP | ||
653 | |a necroptosis | ||
653 | |a neurodegeneration | ||
653 | |a small molecules | ||
653 | |a hyperglycemia | ||
653 | |a hyperinsulinemia | ||
653 | |a S100B protein | ||
653 | |a oxidative stress | ||
653 | |a central nervous system (CNS) | ||
653 | |a cancer | ||
653 | |a type 2 diabetes (T2DM) | ||
653 | |a neuropsychiatric disorders | ||
653 | |a mood disorders | ||
653 | |a cytokines | ||
653 | |a blood-brain barrier (BBB) | ||
653 | |a FLIM | ||
653 | |a brain injuries | ||
653 | |a traumatic | ||
653 | |a diffuse axonal injury | ||
653 | |a geniculate bodies | ||
653 | |a mice | ||
653 | |a nerve degeneration | ||
653 | |a neurofilament proteins | ||
653 | |a neuroglia | ||
653 | |a optic tract | ||
653 | |a superior colliculi | ||
653 | |a synaptophysin | ||
653 | |a TDP-43 proteinopathies | ||
653 | |a apoptosis | ||
653 | |a necrosis | ||
653 | |a docosahexaenoic acid | ||
653 | |a neurodegenerative disease | ||
653 | |a inflammation | ||
653 | |a nanomedicine | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4838 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/78746 |7 0 |z DOAB: description of the publication |